Dr. Agarwal's Eye [DRAGARWQ] vs Shalby [SHALBY] Detailed Stock Comparison
Dr. Agarwal's Eye
BSE
Loading...
Shalby
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Dr. Agarwal's Eye wins in 12 metrics, Shalby wins in 7 metrics, with 0 ties. Dr. Agarwal's Eye appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Dr. Agarwal's Eye | Shalby | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 36.63 | 1,128.89 | Dr. Agarwal's Eye |
| Price-to-Book Ratio | 10.09 | 2.00 | Shalby |
| Debt-to-Equity Ratio | 158.94 | 47.82 | Shalby |
| PEG Ratio | 1.64 | 21.62 | Dr. Agarwal's Eye |
| EV/EBITDA | 18.64 | 16.40 | Shalby |
| Profit Margin (TTM) | 13.96% | -0.05% | Dr. Agarwal's Eye |
| Operating Margin (TTM) | 22.71% | 10.55% | Dr. Agarwal's Eye |
| EBITDA Margin (TTM) | 22.71% | 10.55% | Dr. Agarwal's Eye |
| Return on Equity | 26.07% | 0.63% | Dr. Agarwal's Eye |
| Return on Assets (TTM) | 8.91% | 0.37% | Dr. Agarwal's Eye |
| Free Cash Flow (TTM) | $-83.80M | $-757.89M | Dr. Agarwal's Eye |
| Dividend Yield | 0.11% | 0.65% | Shalby |
| 1-Year Return | 13.88% | -23.54% | Dr. Agarwal's Eye |
| Price-to-Sales Ratio (TTM) | 5.11 | 1.98 | Shalby |
| Enterprise Value | $24.24B | $26.27B | Shalby |
| EV/Revenue Ratio | 5.85 | 2.42 | Shalby |
| Gross Profit Margin (TTM) | 58.67% | 37.50% | Dr. Agarwal's Eye |
| Revenue per Share (TTM) | $881 | $88 | Dr. Agarwal's Eye |
| Earnings per Share (Diluted) | $122.87 | $0.18 | Dr. Agarwal's Eye |
| Beta (Stock Volatility) | -0.35 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Dr. Agarwal's Eye vs Shalby Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Dr. Agarwal's Eye | -0.51% | 3.11% | 1.38% | 8.24% | 10.72% | -30.48% |
| Shalby | -0.55% | -1.22% | 10.72% | 6.94% | 0.48% | -12.09% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Dr. Agarwal's Eye | 13.88% | 469.51% | 1,862.42% | 3,004.00% | 5,456.54% | 10,342.69% |
| Shalby | -23.54% | 60.19% | 132.49% | -15.19% | -15.19% | -15.19% |
Performance & Financial Health Analysis: Dr. Agarwal's Eye vs Shalby
| Metric | DRAGARWQ | SHALBY |
|---|---|---|
| Market Information | ||
| Market Cap | ₹21.15B | ₹21.86B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 1,335 | 191,005 |
| 90 Day Avg. Volume | 1,326 | 333,871 |
| Last Close | ₹4,477.75 | ₹202.08 |
| 52 Week Range | ₹3,500.00 - ₹7,300.00 | ₹177.25 - ₹297.90 |
| % from 52W High | -38.66% | -32.17% |
| All-Time High | ₹7,300.00 (Dec 30, 2024) | ₹339.50 (Jan 22, 2024) |
| % from All-Time High | -38.66% | -40.48% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.17% | 0.09% |
| Quarterly Earnings Growth | 0.22% | -0.46% |
| Financial Health | ||
| Profit Margin (TTM) | 0.14% | 0.00% |
| Operating Margin (TTM) | 0.23% | 0.11% |
| Return on Equity (TTM) | 0.26% | 0.01% |
| Debt to Equity (MRQ) | 158.94 | 47.82 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹445.96 | ₹101.79 |
| Cash per Share (MRQ) | ₹52.76 | N/A |
| Operating Cash Flow (TTM) | ₹756.10M | ₹-417,020,000 |
| Levered Free Cash Flow (TTM) | ₹546.50M | ₹62.22M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.11% | 0.65% |
| Last 12-Month Dividend | ₹5.00 | ₹1.20 |
Valuation & Enterprise Metrics Analysis: Dr. Agarwal's Eye vs Shalby
| Metric | DRAGARWQ | SHALBY |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 36.63 | 1,128.89 |
| Forward P/E | 463.05 | 21.62 |
| PEG Ratio | 1.64 | 21.62 |
| Price to Sales (TTM) | 5.11 | 1.98 |
| Price to Book (MRQ) | 10.09 | 2.00 |
| Market Capitalization | ||
| Market Capitalization | ₹21.15B | ₹21.86B |
| Enterprise Value | ₹24.24B | ₹26.27B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.85 | 2.42 |
| Enterprise to EBITDA | 18.64 | 16.40 |
| Risk & Other Metrics | ||
| Beta | -0.35 | N/A |
| Book Value per Share (MRQ) | ₹445.96 | ₹101.79 |
Financial Statements Comparison: Dr. Agarwal's Eye vs Shalby
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | DRAGARWQ | SHALBY |
|---|---|---|
| Revenue/Sales | ₹1.17B | ₹2.65B |
| Cost of Goods Sold | ₹483.20M | ₹1.66B |
| Gross Profit | ₹686.00M | ₹993.23M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹265.50M | ₹46.11M |
| EBITDA | ₹379.30M | ₹261.61M |
| Pre-Tax Income | ₹231.90M | ₹-7.38M |
| Income Tax | ₹59.30M | ₹114.50M |
| Net Income (Profit) | ₹172.60M | ₹-121.88M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | DRAGARWQ | SHALBY |
|---|---|---|
| Cash & Equivalents | ₹111.60M | ₹347.85M |
| Total Current Assets | ₹559.40M | ₹6.58B |
| Total Current Liabilities | ₹869.80M | ₹4.55B |
| Long-Term Debt | ₹3.06B | ₹1.75B |
| Total Shareholders Equity | ₹2.10B | ₹9.95B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹3.65B | ₹8.88B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | DRAGARWQ | SHALBY |
|---|---|---|
| Operating Cash Flow | N/A | ₹433.19M |
| Capital Expenditures | N/A | ₹-563.59M |
| Free Cash Flow | N/A | ₹-66.61M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | DRAGARWQ | SHALBY |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 1,335 | 191,005 |
| Average Daily Volume (90 Day) | 1,326 | 333,871 |
| Shares Outstanding | 4.70M | 107.27M |
| Float Shares | 1.11M | 31.05M |
| % Held by Insiders | 0.78% | 0.77% |
| % Held by Institutions | 0.02% | 0.00% |
Dividend Analysis & Yield Comparison: Dr. Agarwal's Eye vs Shalby
| Metric | DRAGARWQ | SHALBY |
|---|---|---|
| Last 12-Month Dividend | ₹5.00 | ₹1.20 |
| Last 12-Month Dividend Yield | 0.11% | 0.65% |
| 3-Year Avg Annual Dividend | ₹4.50 | ₹1.08 |
| 3-Year Avg Dividend Yield | 0.12% | 0.55% |
| 3-Year Total Dividends | ₹13.50 | ₹3.23 |
| Ex-Dividend Date | Nov 08, 2024 | Sep 19, 2024 |